Schrodinger Cash on Hand 2019-2024 | SDGR

Schrodinger cash on hand from 2019 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Schrodinger Annual Cash on Hand
(Millions of US $)
2023 $469
2022 $456
2021 $579
2020 $643
2019 $86
2018 $84
Schrodinger Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $436
2023-12-31 $469
2023-09-30 $503
2023-06-30 $554
2023-03-31 $532
2022-12-31 $456
2022-09-30 $479
2022-06-30 $513
2022-03-31 $529
2021-12-31 $579
2021-09-30 $600
2021-06-30 $617
2021-03-31 $649
2020-12-31 $643
2020-09-30 $599
2020-06-30 $285
2020-03-31 $289
2019-12-31 $86
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $84
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.461B $0.217B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.257B 19.36
Tempus AI (TEM) United States $5.669B 0.00
Hims & Hers Health (HIMS) United States $4.401B 0.00
Inspire Medical Systems (INSP) United States $3.980B 0.00
Axonics (AXNX) United States $3.445B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.202B 0.00
IRhythm Technologies (IRTC) United States $3.010B 0.00
Azenta (AZTA) United States $2.800B 157.42
Enovis (ENOV) United States $2.438B 18.07
10x Genomics (TXG) United States $2.234B 0.00
Privia Health (PRVA) United States $2.022B 113.00
Omnicell (OMCL) United States $1.229B 42.48
Phreesia (PHR) United States $1.177B 0.00
Standard BioTools (LAB) United States $0.682B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Clover Health Investments (CLOV) United States $0.621B 0.00
Fulgent Genetics (FLGT) United States $0.596B 0.00
Health Catalyst (HCAT) United States $0.365B 0.00
Talkspace (TALK) United States $0.365B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.305B 0.00
Pulmonx (LUNG) United States $0.245B 0.00
Butterfly Network (BFLY) United States $0.209B 0.00
Outset Medical (OM) United States $0.199B 0.00
TruBridge (TBRG) United States $0.168B 9.02
P3 Health Partners (PIII) United States $0.157B 0.00
American Well (AMWL) United States $0.089B 0.00
111 (YI) China $0.088B 0.00
EUDA Health Holdings (EUDA) Singapore $0.080B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
HeartBeam (BEAT) United States $0.071B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
MSP Recovery (LIFW) United States $0.057B 0.00
Augmedix (AUGX) United States $0.049B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.048B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
CareCloud (CCLD) United States $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.031B 0.00
Movano (MOVE) United States $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Biotricity (BTCY) United States $0.007B 0.00
Transgenomic (PRPO) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00